BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25860576)

  • 1. Clinical applications of gene therapy for primary immunodeficiencies.
    Cicalese MP; Aiuti A
    Hum Gene Ther; 2015 Apr; 26(4):210-9. PubMed ID: 25860576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of gene therapy for primary immune deficiencies.
    Aiuti A; Roncarolo MG
    Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of primary T cell immunodeficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral vectors for the treatment of primary immunodeficiencies.
    Farinelli G; Capo V; Scaramuzza S; Aiuti A
    J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and prospects: gene therapy for inherited immunodeficiencies.
    Qasim W; Gaspar HB; Thrasher AJ
    Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug.
    Ferrua F; Aiuti A
    Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapies for Primary Immune Deficiencies.
    Kohn LA; Kohn DB
    Front Immunol; 2021; 12():648951. PubMed ID: 33717203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of inherited immunodeficiencies.
    Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
    Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for primary immunodeficiencies: current status and future prospects.
    Qasim W; Gennery AR
    Drugs; 2014 Jun; 74(9):963-9. PubMed ID: 24848753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency.
    Ferrua F; Brigida I; Aiuti A
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):551-6. PubMed ID: 20966749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for severe combined immunodeficiencies.
    Gaspar HB; Thrasher AJ
    Expert Opin Biol Ther; 2005 Sep; 5(9):1175-82. PubMed ID: 16120048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
    Sauer AV; Di Lorenzo B; Carriglio N; Aiuti A
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):527-34. PubMed ID: 25207699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
    Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for severe combined immunodeficiencies and beyond.
    Fischer A; Hacein-Bey-Abina S
    J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for primary immunodeficiencies: Part 2.
    Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
    Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for primary immunodeficiencies: Part 1.
    Cavazzana-Calvo M; Fischer A; Hacein-Bey-Abina S; Aiuti A
    Curr Opin Immunol; 2012 Oct; 24(5):580-4. PubMed ID: 22981681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parachuting in the epigenome: the biology of gene vector insertion profiles in the context of clinical trials.
    Baum C
    EMBO Mol Med; 2011 Feb; 3(2):75-7. PubMed ID: 21254403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.
    Cassani B; Montini E; Maruggi G; Ambrosi A; Mirolo M; Selleri S; Biral E; Frugnoli I; Hernandez-Trujillo V; Di Serio C; Roncarolo MG; Naldini L; Mavilio F; Aiuti A
    Blood; 2009 Oct; 114(17):3546-56. PubMed ID: 19652199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.